Our Surgeons

Boris Gershman MD is an assistant professor of surgery (clinical) (urology) at The Warren Alpert Medical School of Brown University.  Dr. Gershman's clinical interests focus on urologic oncology, including the management of prostate, kidney, bladder, and testicular cancer.  He has a broad research interest in comparative effectiveness and health services research, with a particular focus on risk-stratification for urologic malignancies and quality measurement.

Gershman graduated magna cum laude from Brown University and received his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed residency training at the Massachusetts General Hospital followed by a Society of Urologic Oncology (SUO) fellowship at Mayo Clinic.  He has received numerous institutional and organizational honors and awards including the Maria L. Caleel Memorial Award for Academic Excellence, the Dr. I. S. Ravdin Memorial Prize in Surgery, the Dr. Spencer Morris Prize, and induction into the Alpha Omega Alpha medical honor society. He serves as a reviewer for multiple journals, and has been recognized as Reviewer of the Year by European Urology.

Director, Minimally Invasive Urology Institute; Director, Genitourinary Oncology at The Miriam Hospital

Dragan Golijanin, MD, is a director of the Minimally Invasive Urology Institute and director of Genitourinary Oncology at The Miriam Hospital. He also serves as an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include prostate cancer, kidney cancer, bladder cancer and testicular cancer. Golijanin is board certified in urology.

Golijanin earned his medical degree at the University of Belgrade. He completed residencies at the University of Rochester School of Medicine, University Clinical Center in Belgrade and Hadassah Medical Center. He completed fellowships in urologic oncology at Memorial Sloan-Kettering Cancer Center and Cornell University and Hadassah Medical Center, and was the first to publish on near-infrared real-time imaging in open laparoscopic and robotic surgery.

 

E. Bradley Miller, MD is a clinical assistant professor of surgery (urology) at The Warren Alpert Medical School of Brown University. He graduated from the University of Massachusetts Medical School (Worcester) and completed his urology training at Eastern Virginia Medical School in Norfolk, Virginia.

Miller received extensive training in reconstructive urologic surgery at the Devine Reconstructive Center in Norfolk,Virginia. His focus is in urologic oncology, reconstruction, and minimally invasive surgery. He is board-certified by the American Board of Urology and is a member of the Society of Genitourinary Reconstructive Surgery.  

Director of Minimally Invasive Urologic Surgery

Gyan Pareek, MD, is a director of the Minimally Invasive Urology Institute and director of the Kidney Stone Center at The Miriam Hospital. He is also an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include kidney stones, prostate cancer and benign prostatic hyperplasia. Pareek is board certified in urology and is a fellow of the American College of Surgeons.

Pareek earned his medical degree from St. George’s University School of Medicine and completed his residency at Lenox Hill Hospital in New York. He also completed his laparoscopy and endourology fellowship at the University of Wisconsin. In 2006, Pareek was part of a team at The Miriam Hospital that performed the first robotic prostatectomy in the state of Rhode Island. He is on the board of directors for University Urology Associates, Bay Area Mobile Medical, and New England American Urological Association and is president of the Rhode Island Urological Society.

Director, Minimally Invasive Urology Institute

Joseph F.Renzulli II, MD, is a director of the Minimally Invasive Urology Institute and director of the Prostate Surgery Program at The Miriam Hospital. He is also an associate professor of surgery (urology) at The Warren Alpert Medical School of Brown University. His areas of expertise include prostate cancer, kidney cancer, bladder cancer and testicular cancer. Renzulli is board certified in urology and is a fellow of the American College of Surgeons.

Renzulli received his medical degree from Boston University and later completed his residency at Yale University School of Medicine. In 2006, Renzulli was part of a team at The Miriam Hospital that performed the first robotic prostatectomy in the state of Rhode Island.